panblok
Vaccineexperimental
Clinical trial activity
5 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2010 (NCT01147068)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- panblok
- rha
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05608005 | Phase 2 | Nov 3, 2022 | Sanofi-Aventis |
| NCT03283319 | Phase 2 | Sep 20, 2017 | Central Kentucky Research Assoc, Inc, Department of Health and Human Services, Heartland Research Associates, LLC, Johnson County Clin-Trials, Rho, Inc., Rochester Clinical Research |
| NCT02464163 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2015 | Protein Sciences Corp, University of Rochester |
| NCT01612000 | Phase 1/Phase 2 (Phase 2) | May 1, 2012 | Protein Sciences Corp, University of Rochester |
| NCT01147068 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2010 | Protein Sciences Corp, University of Rochester |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Protein Sciences Corp | For profit | 3 | 3 | 1 | 2010 |
| University of Rochester | Academic/Hospital | 3 | 0 | 1 | 2010 |
| Central Kentucky Research Assoc, Inc | For profit | 1 | 0 | 1 | 2017 |
| Department of Health and Human Services | Government | 1 | 1 | 1 | 2017 |
| Heartland Research Associates, LLC | For profit | 1 | 0 | 1 | 2017 |
| Johnson County Clin-Trials | For profit | 1 | 0 | 1 | 2017 |
| Rho, Inc. | For profit | 1 | 0 | 1 | 2017 |
| Rochester Clinical Research | For profit | 1 | 0 | 1 | 2017 |
| Sanofi-Aventis | For profit | 1 | 1 | 1 | 2022 |
9 organizations
Page 1 / 1